+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Surface Markers Market Research Report by Product (Antibodies and Pcr Arrays), Source, Cell Type, Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4995211
  • Report
  • April 2022
  • Region: Global
  • 212 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abcam
  • Biolegend
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cell Signaling Technology
  • Danaher Corporation
The Global Cell Surface Markers Market size was estimated at USD 660.37 million in 2021, USD 719.97 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.20% to reach USD 1,119.95 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cell Surface Markers to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Antibodies and Pcr Arrays.
  • Based on Source, the market was studied across Mice and Rats.
  • Based on Cell Type, the market was studied across B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, and T Cell Surface Markers.
  • Based on Application, the market was studied across Clinical and Research. The Clinical is further studied across Immunodeficiency Diseases and Oncology. The Research is further studied across Drug Discovery, Immunology, and Stem Cell Research.
  • Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Surface Markers market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Surface Markers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Surface Markers Market, including Abcam, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne, Biolegend, Cell Signaling Technology, Danaher Corporation, F. Hoffman-La Roche, Genscript, Merk KGaA, Qiagen N.V., and Thermo Fisher Scientific.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cell Surface Markers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Surface Markers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Surface Markers Market?
4. What is the competitive strategic window for opportunities in the Global Cell Surface Markers Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Surface Markers Market?
6. What is the market share of the leading vendors in the Global Cell Surface Markers Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Surface Markers Market?
Frequently Asked Questions about the Global Cell Surface Markers Market

What is the estimated value of the Global Cell Surface Markers Market?

The Global Cell Surface Markers Market was estimated to be valued at $660.4 Million in 2021.

What is the growth rate of the Global Cell Surface Markers Market?

The growth rate of the Global Cell Surface Markers Market is 9.2%, with an estimated value of $1120.0 Million by 2027.

What is the forecasted size of the Global Cell Surface Markers Market?

The Global Cell Surface Markers Market is estimated to be worth $1120.0 Million by 2027.

Who are the key companies in the Global Cell Surface Markers Market?

Key companies in the Global Cell Surface Markers Market include Abcam, Becton, Dickinson and Company, Bio, Rad Laboratories, Bio, Techne, Biolegend, Cell Signaling Technology and F. Hoffman.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam
  • Biolegend
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cell Signaling Technology
  • Danaher Corporation

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing automation in the laboratories
5.1.1.2. Rising need for adoption of in vitro diagnostics
5.1.1.3. Growing occurrence rate of cancer and other autoimmune diseases
5.1.2. Restraints
5.1.2.1. Disinclination for investment in sophisticated models
5.1.3. Opportunities
5.1.3.1. Growing investment in research and development to launch new drugs
5.1.3.2. Rising technological advancement in the healthcare sector
5.1.4. Challenges
5.1.4.1. Complexity and cost associated with instruments
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cell Surface Markers Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. Pcr Arrays
7. Cell Surface Markers Market, by Source
7.1. Introduction
7.2. Mice
7.3. Rats
8. Cell Surface Markers Market, by Cell Type
8.1. Introduction
8.2. B Cell Surface Markers
8.3. Monocyte Cell Surface Markers
8.4. NK Cell Surface Markers
8.5. T Cell Surface Markers
9. Cell Surface Markers Market, by Application
9.1. Introduction
9.2. Clinical
9.2.1. Immunodeficiency Diseases
9.2.2. Oncology
9.3. Research
9.3.1. Drug Discovery
9.3.2. Immunology
9.3.3. Stem Cell Research
10. Cell Surface Markers Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Clinical Testing Laboratories
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Cell Surface Markers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cell Surface Markers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abcam
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories
15.4. Bio-Techne
15.5. Biolegend
15.6. Cell Signaling Technology
15.7. Danaher Corporation
15.8. F. Hoffman-La Roche
15.9. Genscript
15.10. Merk KGaA
15.11. Qiagen N.V.
15.12. Thermo Fisher Scientific
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CELL SURFACE MARKERS MARKET: DYNAMICS
FIGURE 2. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2027
FIGURE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MICE, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RATS, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (%)
FIGURE 17. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2027
FIGURE 19. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 28. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2027
FIGURE 30. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 45. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2027
FIGURE 47. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 53. AMERICAS CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. BRAZIL CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. CANADA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. MEXICO CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. CHINA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. INDIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. INDONESIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. JAPAN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. TAIWAN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. THAILAND CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. FRANCE CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. GERMANY CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. ITALY CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. QATAR CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. RUSSIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. SPAIN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. GLOBAL CELL SURFACE MARKERS MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL CELL SURFACE MARKERS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL SURFACE MARKERS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CELL SURFACE MARKERS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 78. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 94. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 96. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. AMERICAS CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. BRAZIL CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. CANADA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. MEXICO CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. CHINA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. INDIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. INDONESIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. JAPAN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. TAIWAN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. THAILAND CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. FRANCE CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. GERMANY CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 119. ITALY CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. QATAR CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 122. RUSSIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. SPAIN CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. GLOBAL CELL SURFACE MARKERS MARKET: SCORES
TABLE 129. GLOBAL CELL SURFACE MARKERS MARKET: BUSINESS STRATEGY
TABLE 130. GLOBAL CELL SURFACE MARKERS MARKET: PRODUCT SATISFACTION
TABLE 131. GLOBAL CELL SURFACE MARKERS MARKET: RANKING
TABLE 132. GLOBAL CELL SURFACE MARKERS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 133. GLOBAL CELL SURFACE MARKERS MARKET: MERGER & ACQUISITION
TABLE 134. GLOBAL CELL SURFACE MARKERS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 135. GLOBAL CELL SURFACE MARKERS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 136. GLOBAL CELL SURFACE MARKERS MARKET: INVESTMENT & FUNDING
TABLE 137. GLOBAL CELL SURFACE MARKERS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 138. GLOBAL CELL SURFACE MARKERS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abcam
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Bio-Techne
  • Biolegend
  • Cell Signaling Technology
  • Danaher Corporation
  • F. Hoffman-La Roche
  • Genscript
  • Merk KGaA
  • Qiagen N.V.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

Loading
LOADING...